Current and Emerging Concepts for Optimizing Outcomes in HR+/HER2- Breast Cancer: The Role of CDK4/6 Inhibitors


Share

Program Content

Activities

  • Current and Emerging Concepts for Optimizing Outcomes in HR+/HER2- Breast Cancer: The Role of CDK4/6 Inhibitors
    Current and Emerging Concepts for Optimizing Outcomes in HR+/HER2- Breast Cancer: The Role of CDK4/6 Inhibitors
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 24, 2021

    Expires: November 23, 2022

Provided by

ProCE Banner